Galderma (SIX: GALD), today announced that regulatory authorities in the EU, the U.S., and Canada have approved a new state-of-the-art syringe for use with its NASHA® lidocaine range of Restylane ...
Key market opportunities in the Prefilled Syringes Market include rapid growth driven by GLP-1 obesity therapeutics and rising self-injection demand, preference for COP over glass to mitigate ...
As billions from opioid settlements pour into states, Pennsylvania's efforts against addiction could be hamstrung because clean syringes could be... In Pennsylvania, she wants to hand out new syringes ...